Clinical Research in Cardiology

, Volume 101, Issue 4, pp 317–320 | Cite as

Severe left main coronary stenosis in a young female patient, 6 years after mediastinal radiation therapy for non-Hodgkin lymphoma: assessment by coronary angiography and intravascular ultrasound

  • Grigorios Korosoglou
  • Arnt V. Kristen
  • Martin Andrassy
  • Hugo A. Katus
  • Stefan E. Hardt
Letter to the Editors

Supplementary material

392_2012_413_MOESM1_ESM.gif (25.8 mb)
Supplementary material 1 (GIF 25.7 mb)
392_2012_413_MOESM2_ESM.gif (22.5 mb)
Supplementary material 2 (GIF 22.5 mb)

References

  1. 1.
    Ferme C, Eghbali H, Meerwaldt JH et al (2007) Chemotherapy plus involved-field radiation in early-stage Hodgkin’s disease. N Engl J Med 357:1916–1927PubMedCrossRefGoogle Scholar
  2. 2.
    Allemani C, Sant M, De Angelis R, Marcos-Gragera R, Coebergh JW (2006) Hodgkin disease survival in Europe and the U.S.: prognostic significance of morphologic groups. Cancer 107:352–360PubMedCrossRefGoogle Scholar
  3. 3.
    Moser EC, Noordijk EM, van Leeuwen FE et al (2006) Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma. Blood 107:2912–2919PubMedCrossRefGoogle Scholar
  4. 4.
    Galper SL, Yu JB, Mauch PM et al (2011) Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation. Blood 117:412–418PubMedCrossRefGoogle Scholar
  5. 5.
    Machann W, Beer M, Breunig M et al (2011) Cardiac magnetic resonance imaging findings in 20-year survivors of mediastinal radiotherapy for Hodgkin’s disease. Int J Radiat Oncol Biol Phys 79:1117–1123PubMedCrossRefGoogle Scholar
  6. 6.
    Hull MC, Morris CG, Pepine CJ, Mendenhall NP (2003) Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA 290:2831–2837PubMedCrossRefGoogle Scholar
  7. 7.
    Lund MB, Ihlen H, Voss BM et al (1996) Increased risk of heart valve regurgitation after mediastinal radiation for Hodgkin’s disease: an echocardiographic study. Heart 75:591–595PubMedCrossRefGoogle Scholar
  8. 8.
    Schultz-Hector S, Trott KR (2007) Radiation-induced cardiovascular diseases: is the epidemiologic evidence compatible with the radiobiologic data? Int J Radiat Oncol Biol Phys 67:10–18PubMedCrossRefGoogle Scholar
  9. 9.
    Heidenreich PA, Schnittger I, Strauss HW et al (2007) Screening for coronary artery disease after mediastinal irradiation for Hodgkin’s disease. J Clin Oncol 25:43–49PubMedCrossRefGoogle Scholar
  10. 10.
    Hodgson DC (2011) Late effects in the era of modern therapy for Hodgkin lymphoma. Hematol Am Soc Hematol Educ Program 2011:323–329CrossRefGoogle Scholar
  11. 11.
    Miller TP, Dahlberg S, Cassady JR et al (1998) Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin’s lymphoma. N Engl J Med 339:21–26PubMedCrossRefGoogle Scholar
  12. 12.
    Wilder RB, Rodriguez MA, Tucker SL et al (2001) Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas. Int J Radiat Oncol Biol Phys 50:743–749PubMedCrossRefGoogle Scholar
  13. 13.
    Alm El-Din MA, El-Badawy SA, Taghian AG (2008) Breast cancer after treatment of Hodgkin’s lymphoma: general review. Int J Radiat Oncol Biol Phys 72:1291–1297PubMedCrossRefGoogle Scholar
  14. 14.
    Lauk S, Trott KR (1988) Radiation induced heart disease in hypertensive rats. Int J Radiat Oncol Biol Phys 14:109–114PubMedCrossRefGoogle Scholar
  15. 15.
    Stewart FA, Heeneman S, Te Poele J et al (2006) Ionizing radiation accelerates the development of atherosclerotic lesions in ApoE-/- mice and predisposes to an inflammatory plaque phenotype prone to hemorrhage. Am J Pathol 168:649–658PubMedCrossRefGoogle Scholar
  16. 16.
    Darby SC, Cutter DJ, Boerma M et al (2010) Radiation-related heart disease: current knowledge and future prospects. Int J Radiat Oncol Biol Phys 76:656–665PubMedCrossRefGoogle Scholar
  17. 17.
    Kim WH, Lee BK, Lee S et al (2010) Serial changes of minimal stent malapposition not detected by intravascular ultrasound: follow-up optical coherence tomography study. Clin Res Cardiol 99:639–644PubMedCrossRefGoogle Scholar
  18. 18.
    Aleman BM, van den Belt-Dusebout AW, De Bruin ML et al (2007) Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 109:1878–1886PubMedCrossRefGoogle Scholar
  19. 19.
    Glanzmann C, Kaufmann P, Jenni R, Hess OM, Huguenin P (1998) Cardiac risk after mediastinal irradiation for Hodgkin’s disease. Radiother Oncol 46:51–62PubMedCrossRefGoogle Scholar
  20. 20.
    Rademaker J, Schoder H, Ariaratnam NS et al (2008) Coronary artery disease after radiation therapy for Hodgkin’s lymphoma: coronary CT angiography findings and calcium scores in nine asymptomatic patients. Am J Roentgenol 191:32–37CrossRefGoogle Scholar
  21. 21.
    Andersen R, Wethal T, Gunther A et al (2010) Relation of coronary artery calcium score to premature coronary artery disease in survivors > 15 years of Hodgkin’s lymphoma. Am J Cardiol 105:149–152PubMedCrossRefGoogle Scholar
  22. 22.
    Kupeli S, Hazirolan T, Varan A et al (2010) Evaluation of coronary artery disease by computed tomography angiography in patients treated for childhood Hodgkin’s lymphoma. J Clin Oncol 28:1025–1030PubMedCrossRefGoogle Scholar
  23. 23.
    Templin C, Ghadri JR, Wyss C, Luscher TF, Kaufmann P, Landmesser U (2010) Severe left main coronary stenosis and mitral regurgitation in a young female patient without cardiovascular risk factors 14 years after mediastinal radiation therapy. Clin Res Cardiol 99:199–201PubMedCrossRefGoogle Scholar
  24. 24.
    Biondi-Zoccai GG, Giraudi E, Moretti C et al (2010) Impact of routine angiographic follow-up after percutaneous coronary drug-eluting stenting for unprotected left main disease: the Turin Registry. Clin Res Cardiol 99:235–242PubMedCrossRefGoogle Scholar
  25. 25.
    Rittger H, Rieber J, Kogler K et al (2011) Clinical outcome and quality of life after interventional treatment of left main disease with drug-eluting-stents in comparison to CABG in elderly and younger patients. Clin Res Cardiol 100:439–446PubMedCrossRefGoogle Scholar
  26. 26.
    Schachinger V, Herdeg C, Scheller B (2010) Best way to revascularize patients with main stem and three vessel lesions: patients should undergo PCI! Clin Res Cardiol 99:531–539PubMedCrossRefGoogle Scholar
  27. 27.
    Merkle N, Wohrle J, Nusser T et al (2010) Diagnostic performance of magnetic resonance first pass perfusion imaging is equally potent in female compared to male patients with coronary artery disease. Clin Res Cardiol 99:21–28PubMedCrossRefGoogle Scholar
  28. 28.
    Prosnitz RG, Hubbs JL, Evans ES et al (2007) Prospective assessment of radiotherapy-associated cardiac toxicity in breast cancer patients: analysis of data 3 to 6 years after treatment. Cancer 110:1840–1850PubMedCrossRefGoogle Scholar
  29. 29.
    Lee DC, Simonetti OP, Harris KR et al (2004) Magnetic resonance versus radionuclide pharmacological stress perfusion imaging for flow-limiting stenoses of varying severity. Circulation 110:58–65PubMedCrossRefGoogle Scholar
  30. 30.
    Korosoglou G, Mueller D, Lehrke S et al (2010) Quantitative assessment of stenosis severity and atherosclerotic plaque composition using 256-slice computed tomography. Eur Radiol 20:1841–1850PubMedCrossRefGoogle Scholar
  31. 31.
    Hosch W, Heye T, Schulz F et al (2011) Image quality and radiation dose in 256-slice cardiac computed tomography: comparison of prospective versus retrospective image acquisition protocols. Eur J Radiol 80:127–135PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Grigorios Korosoglou
    • 1
  • Arnt V. Kristen
    • 1
  • Martin Andrassy
    • 1
  • Hugo A. Katus
    • 1
  • Stefan E. Hardt
    • 1
  1. 1.Department of CardiologyUniversity of HeidelbergHeidelbergGermany

Personalised recommendations